3D HEALTHCARE SOLUTIONS LIMITED

Company Registration Number:
09456485 (England and Wales)

Unaudited statutory accounts for the year ended 28 February 2026

Period of accounts

Start date: 1 March 2025

End date: 28 February 2026

3D HEALTHCARE SOLUTIONS LIMITED

Contents of the Financial Statements

for the Period Ended 28 February 2026

Directors report
Profit and loss
Balance sheet
Additional notes
Balance sheet notes

3D HEALTHCARE SOLUTIONS LIMITED

Directors' report period ended 28 February 2026

The directors present their report with the financial statements of the company for the period ended 28 February 2026

Principal activities of the company

The principal activities of the company during the period was the provision of healthcare support services

Additional information

Statement of director's responsibilities The director is responsible for preparing the directors' report and the financial statements in accordance with applicable law and regulations and in accordance with United Kingdom Generally Accepted Accounting Practice. Company law requires the director to prepare financial statements for each financial year. Under that law the director has elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the director must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and the profit or loss of the company for that period. In preparing these financial statements, the director is required to : select suitable accounting policies and then apply them consistently make judgements and accounting estimates that are reasonable and prudent state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements and prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business. The director is responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. The director is also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities. The director is responsible for the maintenance and integrity of the corporate and financial information included on the company's website. Legislation in the United Kingdom, governing the preparation and dissemination of financial statements, may differ from legislation in other jurisdictions



Directors

The director shown below has held office during the whole of the period from
1 March 2025 to 28 February 2026

Jane Pamela Ndemo


The above report has been prepared in accordance with the special provisions in part 15 of the Companies Act 2006

This report was approved by the board of directors on
24 October 2026

And signed on behalf of the board by:
Name: Jane Pamela Ndemo
Status: Director

3D HEALTHCARE SOLUTIONS LIMITED

Profit And Loss Account

for the Period Ended 28 February 2026

2026 2025


£

£
Turnover: 683,202 507,280
Cost of sales: ( 153,800 ) ( 41,217 )
Gross profit(or loss): 529,402 466,063
Administrative expenses: ( 515,940 ) ( 453,246 )
Other operating income: 8,600 7,040
Operating profit(or loss): 22,062 19,857
Profit(or loss) before tax: 22,062 19,857
Tax: ( 4,192 ) ( 3,773 )
Profit(or loss) for the financial year: 17,870 16,084

3D HEALTHCARE SOLUTIONS LIMITED

Balance sheet

As at 28 February 2026

Notes 2026 2025


£

£
Fixed assets
Tangible assets: 3 10,525 10,525
Total fixed assets: 10,525 10,525
Current assets
Cash at bank and in hand: 159,584 81,743
Total current assets: 159,584 81,743
Creditors: amounts falling due within one year: 4 ( 32,095 ) ( 3,773 )
Net current assets (liabilities): 127,489 77,970
Total assets less current liabilities: 138,014 88,495
Total net assets (liabilities): 138,014 88,495
Capital and reserves
Called up share capital: 100 100
Other reserves: 120,044 72,311
Profit and loss account: 17,870 16,084
Total Shareholders' funds: 138,014 88,495

The notes form part of these financial statements

3D HEALTHCARE SOLUTIONS LIMITED

Balance sheet statements

For the year ending 28 February 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 24 October 2026
and signed on behalf of the board by:

Name: Jane Pamela Ndemo
Status: Director

The notes form part of these financial statements

3D HEALTHCARE SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2026

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

3D HEALTHCARE SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2026

  • 2. Employees

    2026 2025
    Average number of employees during the period 14 10

3D HEALTHCARE SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2026

3. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Motor vehicles Total
Cost £ £ £ £ £ £
At 1 March 2025 10,525 10,525
Additions
Disposals
Revaluations
Transfers
At 28 February 2026 10,525 10,525
Depreciation
At 1 March 2025
Charge for year
On disposals
Other adjustments
At 28 February 2026
Net book value
At 28 February 2026 10,525 10,525
At 28 February 2025 10,525 10,525

3D HEALTHCARE SOLUTIONS LIMITED

Notes to the Financial Statements

for the Period Ended 28 February 2026

4. Creditors: amounts falling due within one year note

2026 2025
£ £
Trade creditors 27,903
Taxation and social security 4,192 3,773
Total 32,095 3,773